Catalog Number: | CL-LROD-12 |
CAS No.: | NA |
Mol.F: | C108H138N22O20S4 |
Mol.W: | 2192.7 |
Inv. Status: | Custom Synthesis |
Chemical Name: (4R,7S,10S,13R,16S,19R,24R,27S,30S,33R,36S,39R)-13,33-bis((1H-indol-3-yl)methyl)-19,39-bis((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N4,N24-bis((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10,30-bis(4-aminobutyl)-16,36-bis(4-hydroxybenzyl)-7,27-diisopropyl-6,9,12,15,18,26,29,32,35,38-decaoxo-1,2,21,22-tetrathia-5,8,11,14,17,25,28,31,34,37-decaazacyclotetracontane-4,24-dicarboxamide.
Country of Origin: India
Product Category: Lanreotide Impurities
Lanreotide Anti-parallel Dimer is identified by CAS No. NA and is chemically known as (4R,7S,10S,13R,16S,19R,24R,27S,30S,33R,36S,39R)-13,33-bis((1H-indol-3-yl)methyl)-19,39-bis((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N4,N24-bis((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10,30-bis(4-aminobutyl)-16,36-bis(4-hydroxybenzyl)-7,27-diisopropyl-6,9,12,15,18,26,29,32,35,38-decaoxo-1,2,21,22-tetrathia-5,8,11,14,17,25,28,31,34,37-decaazacyclotetracontane-4,24-dicarboxamide.
Lanreotide Anti-parallel Dimer is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Lanreotide.
Page Keywords: Buy Lanreotide Anti-parallel Dimer | Purchase Lanreotide Anti-parallel Dimer | Lanreotide Anti-parallel Dimer suppliers | Lanreotide Anti-parallel Dimer manufacturers | Lanreotide Anti-parallel Dimer price | Lanreotide Anti-parallel Dimer Importer | Lanreotide Anti-parallel Dimer Exporter